ArticleProtein science : a publication of the Protein Society2025
Comparative assessment of binding residue predictions in intrinsically disordered regions.
Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative assessment of binding residue predictions in intrinsically disordered regions.Protein science : a publication of the Protein Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Dozens of impactful methods that predict intrinsically disordered regions (IDRs) in protein sequences that interact with proteins and/or nucleic acids were developed. Their training and assessment rely on the IDR-level binding annotations, while the equivalent structure-trained methods predict more granular annotations of binding amino acids (AA). We compiled a new benchmark dataset that annotates binding AA in IDRs and applied it to complete a first-of-its-kind assessment of predictions of the disordered binding residues. We evaluated a representative collection of 14 methods, used several hundred low-similarity test proteins, and focused on the challenging task of differentiating these binding residues from other disordered AA and considering ligand type-specific predictions (protein-protein vs. protein-nucleic acid interactions). We found that current methods struggle to accurately predict binding IDRs among disordered residues; however, better-than-random tools predict disordered binding residues significantly better than binding IDRs. We identified at least one relatively accurate tool for predicting disordered protein-binding and disordered nucleic acid-binding AA. Analysis of cross-predictions between interactions with protein and nucleic acids revealed that most methods are ligand-type-agnostic. Only two predictors of the nucleic acid-binding IDRs and two predictors of the protein-binding IDRs can be considered as ligand-type-specific. We also discussed several potential future directions that would move this field forward by producing more accurate methods that target the prediction of binding residues, reduce cross-predictions, and cover a broader range of ligand types.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.